Skip to Content
Søg Menu

2025 ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco – Pioneering Advances in GI Oncology

This year’s ASCO Gastrointestinal (GI) Cancers Symposium highlights groundbreaking research that showcases significant advancements in the understanding and treatment of GI cancers, spanning early-phase clinical trials to practice-changing late-stage studies.

Få adgang

Hvis du er læge, sygeplejerske eller anden sundhedsprofessionel kan du få adgang til hele artiklen ved at oprette en profil på BestPractice Nordic.

Relateret indhold

Xuefeng Leng

Immunotherapy + Chemoradiotherapy Could Lead to More Effective Treatment of Resectable Locally Advanced Esophageal Squamous Cell Carcinoma

/ Xue-Feng Leng
ASCOGI25Esofaguscancer Play the Video 04:25
Laurids Østergaard Poulsen

Imponerende resultater ved dobbelt immunterapi af metastaserende kolorektal cancer

/ Laurids Østergaard Poulsen
ASCOGI25Colorektalcancer Play the Video 07:03
Thierry André

71% Overall Response Rate for Double vs Single Immunotherapy to Patients with Metastatic Colorectal Cancer

/ Thierry André
ASCOGI25Colorektalcancer Play the Video 07:31

LBA Nordic Study: Low-Dose Aspirin Reduces Recurrence in Colorectal Cancer Patients with PI3K Pathway Mutations

/ Jan Andreasen
ASCOGI25

ASCO GI 2025: Danish Study Highlights Efficacy and Safety of Single-Cycle Neoadjuvant Pembrolizumab for Localized dMMR Colon Cancer

/ Amanda Feldballe Bernholm
ASCOGI25

ASCO GI 2025: Everolimus and Lanreotide Combo as a Breakthrough for Gastroenteropancreatic Neuroendocrine Tumors

/ Jan Andreasen
ASCOGI25

Brænder du for at skrive?

Vil du gerne dele din forskning eller dine kliniske erfaringer med dine kollegaer inden for netop dit speciale? Har du en ide til en artikel, som du gerne vil udgive hos os? Send redaktionen en mail på redaktion@bpno.dk

Send mail til redaktionen
Back to top